REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices
REACTION-VAD
Efficacy and Safety of a Remote Conditioning Program in Patients Supported With a Ventricular Assist Device: THE RE-ACTION-VAD TRIAL.
2 other identifiers
interventional
78
1 country
10
Brief Summary
Current international guidelines recommend that patients with a heart pump (left ventricular assist device, LVAD) participate in supervised exercise cardiac rehabilitation programs. However, not all patients with a heart pump are able to attend to a supervised program on a daily basis. The goal of this clinical trial is to determine whether a home-based exercise program helps patients with a heart pump improve their exercise capacity and quality of life, guided by telemedicine tools including a mobile app, smartwatch, and remote medical checkups. The study will also provide information about the safety of this program by monitoring for any issues or symptoms during home activity. The trial aims to answer the following questions:
- Does a 12-week remote exercise program improve patients' exercise capacity? This will be measured using the 6-minute walk test and a cardiopulmonary exercise test.
- Is it safe for patients to follow this exercise plan at home while being monitored through a mobile app and smartwatch?
- Does the program improve quality of life and reduce feelings of anxiety or depression? This will be assessed using widely validated questionnaires, such as the Kansas City Cardiomyopathy Questionnaire. Researchers will compare the remote exercise program to standard care, which usually does not include exercise for patients who are unable to attend the hospital daily. Participants will:
- Join the study voluntarily after signing a consent form.
- Be randomly assigned, with a 50% chance of being in either the exercise group (following a structured plan with a mobile app) or the usual care group (receiving general written advice), to see which approach works best for recovery.
- Follow a 12-week home-based routine if in the exercise group, including warm-up routine, walking or cycling, respiratory exercises, and light strength training, all supported by the mobile app, smartwatch, and professional monitoring.
- Visit the hospital three times over six months for medical checkups, including walking and exercise tests, blood analyses, and questionnaires about physical and emotional health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started May 2026
Longer than P75 for not_applicable heart-failure
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
May 28, 2026
May 1, 2026
3.6 years
March 6, 2026
May 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Six-Minute Walk Test (6MWT)
Difference in walking distance (meters) in the Six-Minute Walk Test (6MWT).
3 months
Secondary Outcomes (17)
Program Safety
6 months
Cardiopulmonary Exercise Test (CPET): peak oxygen consumption (VO₂peak)
3 months
Cardiopulmonary Exercise Test (CPET): VE/VO₂ slope
3 months
Cardiopulmonary Exercise Test (CPET): oxygen consumption at the first and second ventilatory thresholds
3 months
Cardiopulmonary Exercise Test (CPET): ventilatory equivalents
3 months
- +12 more secondary outcomes
Other Outcomes (3)
Program Satisfaction and Adherence
6 months
Comparison of Outcomes Between Remote conditioning and Supervised Rehabilitation
6 months
Evaluation of Outcomes by Sex and by the aim of LVAD
6 months
Study Arms (2)
Remote Exercise Training Via Telemedicine
EXPERIMENTALWarm-up, Respiratory Training, Continuous Aerobic Exercise, and Strength Training. Remote Monitoring via Telemedicine.
Control Group
OTHERUsual care. General Exercise Recommendations (Written Instructions). No Remote Monitoring.
Interventions
The program includes structured warm-up routines, respiratory training, continuous aerobic exercise, and strength training, with remote follow-up conducted via telemedicine.
General Exercise Recommendations (Written Instructions). No Remote Monitoring.
Eligibility Criteria
You may qualify if:
- Recent LVAD Implantation (\<6 months)
- Clinical stability (defined as meeting all of the following criteria): discharge from the LVAD implantation hospitalization, absence of inotropic medication, hemoglobin \>9 g/dL, and no active infection.
- Inability to participate in a supervised rehabilitation program (due to lack of availability, or inability because geographical reasons).
You may not qualify if:
- Functional Inability to Perform Cardiopulmonary Exercise Testing
- Prior Participation in a Supervised Rehabilitation Program (after the LVAD implantation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Puerta de Hierro University Hospitallead
- Carlos III Health Institutecollaborator
Study Sites (10)
Hospital Virgen del Rocío
Seville, Andalusia, 41013, Spain
Hospital Universitario de Salamanca
Salamanca, Castille and León, 37007, Spain
Hospital Clinic de Barcelona
Barcelona, Catalonia, 03036, Spain
Hospital Universitari de Bellvitge
Barcelona, Catalonia, Spain
Complejo Hospitalario Universitario de A Coruña
A Coruña, Galicia, 15006, Spain
Complejo Hospitalario Universitario Santiago de Compostela
Santiago de Compostela, Galicia, 15706, Spain
Hospital Ramon y Cajal
Madrid, Madrid, 28034, Spain
Hospital Clinico San Carlos
Madrid, Madrid, 28040, Spain
Hospital 12 de Octubre
Madrid, Madrid, 28041, Spain
Hospital Puerta de Hierro
Majadahonda, Madrid, 28028, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mercedes Rivas-Lasarte, MD, PhD
Hospital Puerta de Hierro, Madrid (Spain)
- PRINCIPAL INVESTIGATOR
Ramon Garrido Gonzalez, MD
Hospital Puerta de Hierro, Madrid (Spain)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist, MD, PhD
Study Record Dates
First Submitted
March 6, 2026
First Posted
May 28, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2030
Last Updated
May 28, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data are expected to be available beginning in January 2031, following completion of the study and publication of the primary analysis.
- Access Criteria
- Data will be shared with investigators who provide a methodologically sound research proposal and demonstrate legitimate scientific interest.
Upon completion of the project and publication of the primary analysis, the data will be deposited in the Zenodo repository following appropriate anonymization procedures. The dataset will be accompanied by metadata in Zenodo including: (1) data provenance, (2) patient population characteristics, and (3) a detailed description of the study variables. Access to data stored in the internal repository for other investigators with legitimate scientific interest will be subject to approval by the Ethics Committee. This approach ensures compliance with open-access data requirements applicable to publicly funded research projects, while maintaining data within a controlled environment consistent with their nature as personal data.